.Neurocrine Biosciences has obtained its own hoped-for profile in a phase 2 schizophrenia trial, sup...
.Vaderis Therapies' goal to create the initial medication intended exclusively at a particular unusu...
.Sat nav Medicines has actually equipped on its own along with $one hundred thousand in collection A...
.China's Duality Biotherapeutics has submitted (PDF) documentation for a Hong Kong IPO, seeking an u...
.4 months after Mandarin gene modifying firm YolTech Therapies took its own cholesterol disease-focu...
.Indivior is grabbing a little molecule allosteric modulator designed to treat material usage proble...
.Molecular Companions has recognized "suboptimal direct exposure" to its own tetra-specific T-cell e...
.While the biotech financial investment scene in Europe has slowed down somewhat following a COVID-1...
.After raising $213 million in 2023-- among the year's biggest private biotech rounds-- Volume Biosc...
.Welcome to today's Chutes & Ladders, our summary of substantial leadership hirings, firings and ...